• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Cadre Holdings Reports First Quarter 2025 Financial Results

    5/6/25 4:15:00 PM ET
    $CDRE
    Industrial Specialties
    Health Care
    Get the next $CDRE alert in real time by email

    Capitalizes on Continued Strong Demand for Mission Critical Safety Equipment

    Completes Acquisition of Multiple Leading Nuclear Brands, Expanding Geographic Footprint

    Increased Guidance Reflects Completed Acquisition and Reaffirmed Organic Growth Expectations

    2025 Outlook: Net Sales of $618 to $648 Million and Adjusted EBITDA of $112 to $122 Million

    Cadre Holdings, Inc. (NYSE:CDRE) ("Cadre" or "Company"), a global leader in the manufacturing and distribution of safety equipment and other related products for the law enforcement, first responder, military and nuclear markets, announced today its consolidated operating results for the three months ended March 31, 2025.

    • Net sales of $130.1 million for the first quarter
    • Gross profit margin of 43.1% for the first quarter
    • Net income of $9.2 million, or $0.23 per diluted share, for the first quarter
    • Adjusted EBITDA of $20.5 million for the first quarter
    • Adjusted EBITDA margin of 15.8% for the first quarter
    • Declared quarterly cash dividend of $0.095 per share in April 2025.

    "Following a record year, we continued to see strong and recurring demand for our best-in-class, mission-critical safety products in the first quarter," said Warren Kanders, CEO and Chairman. "Despite more pronounced uncertainty in our business environment, we have been pleased with our team's ability to navigate challenges and leverage the Cadre operating model to drive continuous improvement every day. Over the course of our history, Cadre's performance has been resilient through economic, political, geopolitical and other cycles, and we anticipate similar performance as we move ahead. To begin 2025, we are pleased to have delivered another quarter of financial results above expectations, highlighted by gross margins that increased 130 basis points year-over-year."

    Mr. Kanders added, "In April, we completed the acquisition of the Engineering Division from Carr's Group, an important next step in scaling our nuclear safety vertical. With increasing global demand driven by energy, defense, and nuclear waste tailwinds, we believe in the consistent growth profile of the nuclear industry, and today, Cadre is uniquely positioned to deliver unparalleled capabilities in this market to a worldwide customer base. As we look forward, complementing our core organic growth initiatives, M&A remains an essential component of our strategy to continue to build our industry-leading safety platform. Consistent with our patient and disciplined approach, we are actively evaluating a robust pipeline of potential transactions focused on complementary businesses with strong margins, leading and defensible market positions, and recurring revenue."

    First Quarter 2025 Operating Results

    For the quarter ended March 31, 2025, Cadre generated net sales of $130.1 million, as compared to $137.9 million for the quarter ended March 31, 2024, primarily as a result of large order shipment timing for explosive ordnance disposal ("EOD") and armor products, partially offset by recent acquisitions and higher demand for crowd control products.

    For the quarter ended March 31, 2025, Cadre generated gross profit of $56.1 million, as compared to $57.6 million for the quarter ended March 31, 2024.

    Gross profit margin was 43.1% for the quarter ended March 31, 2025, as compared to 41.8% for the quarter ended March 31, 2024, mainly driven by favorable mix, favorable pricing net of material inflation and the absence of inventory step up amortization, partially offset by lower volumes.

    Net income was $9.2 million for the quarter ended March 31, 2025, as compared to net income of $6.9 million for the quarter ended March 31, 2024, primarily as a result of acquisition related costs incurred in 2024.

    Cadre generated $20.5 million of Adjusted EBITDA for the quarter ended March 31, 2025, as compared to $24.5 million for the quarter ended March 31, 2024. Adjusted EBITDA margin was 15.8% for the quarter ended March 31, 2025, as compared to 17.8% for the prior year period.

    Product segment gross profit margin was 44.4% for the first quarter, compared to 43.0% for the prior year period.

    Distribution segment gross profit margin was 21.6% for the first quarter, compared to 23.5% for the prior year period.

    Liquidity, Cash Flows and Capital Allocation

    • Cash and cash equivalents increased by $8.5 million from $124.9 million as of December 31, 2024 to $133.4 million as of March 31, 2025.
    • Total debt decreased by $2.7 million from $223.2 million as of December 31, 2024 to $220.5 million as of March 31, 2025.
    • Net debt (total debt net of cash and cash equivalents) decreased by $11.2 million from $98.3 million as of December 31, 2024 to $87.1 million as of March 31, 2025.
    • Capital expenditures totaled $1.4 million for the three months ended March 31, 2025, compared with $1.3 million for the three months ended March 31, 2024.

    Acquisition of Carr's Engineering Division

    On April 22, 2025, Cadre completed its acquisition of Carr's Engineering Limited (excluding Chirton Engineering) and Carr's Engineering (US), Inc. (together the "Engineering Division"), each a subsidiary of Carr's Group plc ("Carr's Group"), for an enterprise value for the acquisition was £75 million. The Engineering Division is comprised of industry-leading brands including Wälischmiller GmbH, CarrsMSM, Bendalls Engineering, NW Total Engineered Solutions, and NuVision Engineering, Inc.

    Dividend

    On April 22, 2025, the Company announced that its Board of Directors declared a quarterly cash dividend of $0.095 per share, or $0.38 per share on an annualized basis. Cadre's dividend payment will be made on May 16, 2025 to shareholders of record as of the close of business on the record date of May 2, 2025. The declaration of any future dividend is subject to the discretion of the Company's Board of Directors.

    2025 Outlook

    For the full year 2025, Cadre expects to generate net sales in the range of $618 million to $648 million and Adjusted EBITDA in the range of $112 million and $122 million. We expect capital expenditures to be in the range of $8 million to $10 million. These ranges incorporate the estimated impact of tariffs in place today and assume that mitigating actions help offset future potential impacts. Cadre has not provided net income guidance due to the inherent difficulty of forecasting certain types of expenses and gains, which affect net income but not Adjusted EBITDA. Therefore, we do not provide a reconciliation of Adjusted EBITDA guidance to net income guidance.

    Conference Call

    Management will host a conference call on Wednesday, May 7, 2025, at 10:00 a.m. EST to discuss the latest corporate developments and financial results. The dial-in number for callers in the US is (800)-715-9871 and the dial-in number for international callers is 646-307-1963. The access code for all callers is 3272793. A live webcast will also be available on the Company's website at https://www.cadre-holdings.com/.

    A replay of the call will be available through May 21, 2025. To access the replay, please dial 800-770-2030 in the U.S. or +1-609-800-9909 if outside the U.S., and then enter the access code 3272793.

    About Cadre

    Headquartered in Jacksonville, Florida, Cadre is a global leader in the manufacturing and distribution of safety products. Cadre's equipment provides critical protection to allow users to safely and securely perform their duties and protect those around them in hazardous or life-threatening situations. The Company's core products include body armor, explosive ordnance disposal equipment, duty gear and nuclear safety products. Our highly engineered products are utilized in over 100 countries by federal, state and local law enforcement, fire and rescue professionals, explosive ordnance disposal teams, and emergency medical technicians. Our key brands include Safariland® and Med-Eng®, amongst others.

    Use of Non-GAAP Measures

    The Company reports its financial results in accordance with U.S. generally accepted accounting principles ("GAAP"). The press release contains the non-GAAP measures: (i) earnings before interest, taxes, other income or expense, depreciation and amortization ("EBITDA"), (ii) adjusted EBITDA, (iii) adjusted EBITDA margin and (iv) last twelve months adjusted EBITDA. The Company believes the presentation of these non-GAAP measures provides useful information for the understanding of its ongoing operations and enables investors to focus on period- over-period operating performance, and thereby enhances the user's overall understanding of the Company's current financial performance relative to past performance and provides, along with the nearest GAAP measures, a baseline for modeling future earnings expectations. Non-GAAP measures are reconciled to comparable GAAP financial measures within this press release. We do not provide a reconciliation of the non-GAAP guidance measure Adjusted EBITDA for the fiscal year 2025 to net income for the fiscal year 2025, the most comparable GAAP financial measure, due to the inherent difficulty of forecasting certain types of expenses and gains, without unreasonable effort, which affect net income but not Adjusted EBITDA. The Company cautions that non-GAAP measures should be considered in addition to, but not as a substitute for, the Company's reported GAAP results. Additionally, the Company notes that there can be no assurance that the above referenced non-GAAP financial measures are comparable to similarly titled financial measures used by other publicly traded companies.

    Forward-Looking Statements

    Please note that in this press release we may use words such as "appears," "anticipates," "believes," "plans," "expects," "intends," "future," and similar expressions which constitute forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are made based on our expectations and beliefs concerning future events impacting the Company and therefore involve a number of risks and uncertainties. We caution that forward-looking statements are not guarantees and that actual results could differ materially from those expressed or implied in the forward-looking statements. Potential risks and uncertainties that could cause the actual results of operations or financial condition of the Company to differ materially from those expressed or implied by forward-looking statements in this press release, include, but are not limited to, those risks and uncertainties more fully described from time to time in the Company's public reports filed with the Securities and Exchange Commission, including under the section titled "Risk Factors" in the Company's Annual Report on Form 10-K, and/or Quarterly Reports on Form 10-Q, as well as in the Company's Current Reports on Form 8-K. All forward-looking statements included in this press release are based upon information available to the Company as of the date of this press release and speak only as of the date hereof. We assume no obligation to update any forward- looking statements to reflect events or circumstances after the date of this press release.

     

    CADRE HOLDINGS, INC.

    CONDENSED CONSOLIDATED BALANCE SHEETS

    (Unaudited)

    (In thousands, except share and per share amounts)

     

     

     

     

     

     

     

     

     

    March 31, 2025

     

    December 31, 2024

    Assets

     

     

     

     

     

     

    Current assets

     

     

     

     

     

     

    Cash and cash equivalents

     

    $

    133,431

     

     

    $

    124,933

     

    Accounts receivable, net of allowance for doubtful accounts of $858 and $876, respectively

     

     

    82,902

     

     

     

    93,523

     

    Inventories

     

     

    91,786

     

     

     

    82,351

     

    Prepaid expenses

     

     

    17,039

     

     

     

    19,027

     

    Other current assets

     

     

    7,357

     

     

     

    7,737

     

    Total current assets

     

     

    332,515

     

     

     

    327,571

     

    Property and equipment, net of accumulated depreciation and amortization of $56,244 and $54,384, respectively

     

     

    45,080

     

     

     

    45,243

     

    Operating lease assets

     

     

    15,595

     

     

     

    15,454

     

    Deferred tax assets, net

     

     

    4,640

     

     

     

    4,552

     

    Intangible assets, net

     

     

    105,884

     

     

     

    107,544

     

    Goodwill

     

     

    148,611

     

     

     

    148,157

     

    Other assets

     

     

    3,968

     

     

     

    4,192

     

    Total assets

     

    $

    656,293

     

     

    $

    652,713

     

     

     

     

     

     

     

     

    Liabilities, Mezzanine Equity and Shareholders' Equity

     

     

     

     

     

     

    Current liabilities

     

     

     

     

     

     

    Accounts payable

     

    $

    32,122

     

     

    $

    29,644

     

    Accrued liabilities

     

     

    41,604

     

     

     

    46,413

     

    Income tax payable

     

     

    8,560

     

     

     

    6,693

     

    Current portion of long-term debt

     

     

    11,380

     

     

     

    11,375

     

    Total current liabilities

     

     

    93,666

     

     

     

    94,125

     

    Long-term debt

     

     

    209,134

     

     

     

    211,830

     

    Long-term operating lease liabilities

     

     

    10,983

     

     

     

    10,733

     

    Deferred tax liabilities

     

     

    18,101

     

     

     

    18,758

     

    Other liabilities

     

     

    6,847

     

     

     

    5,752

     

    Total liabilities

     

     

    338,731

     

     

     

    341,198

     

     

     

     

     

     

     

     

    Mezzanine equity

     

     

     

     

     

     

    Preferred stock ($0.0001 par value, 10,000,000 shares authorized, no shares issued and outstanding as of March 31, 2025 and December 31, 2024)

     

     

    —

     

     

     

    —

     

     

     

     

     

     

     

     

    Shareholders' equity

     

     

     

     

     

     

    Common stock ($0.0001 par value, 190,000,000 shares authorized, 40,659,585 and 40,607,988 shares issued and outstanding as of March 31, 2025 and December 31, 2024, respectively)

     

     

    4

     

     

     

    4

     

    Additional paid-in capital

     

     

    307,625

     

     

     

    306,821

     

    Accumulated other comprehensive loss

     

     

    (1,535

    )

     

     

    (1,389

    )

    Accumulated earnings

     

     

    11,468

     

     

     

    6,079

     

    Total shareholders' equity

     

     

    317,562

     

     

     

    311,515

     

    Total liabilities, mezzanine equity and shareholders' equity

     

    $

    656,293

     

     

    $

    652,713

     

     

    CADRE HOLDINGS, INC.

    CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

    (Unaudited)

    (In thousands, except share and per share amounts)

     

     

     

     

     

     

     

     

     

    Three Months Ended March 31,

     

     

    2025

     

    2024

    Net sales

     

    $

    130,106

     

     

    $

    137,860

     

    Cost of goods sold

     

     

    73,975

     

     

     

    80,232

     

    Gross profit

     

     

    56,131

     

     

     

    57,628

     

    Operating expenses

     

     

     

     

     

     

    Selling, general and administrative

     

     

    41,753

     

     

     

    40,719

     

    Restructuring and transaction costs

     

     

    698

     

     

     

    3,087

     

    Related party expense

     

     

    128

     

     

     

    1,843

     

    Total operating expenses

     

     

    42,579

     

     

     

    45,649

     

    Operating income

     

     

    13,552

     

     

     

    11,979

     

    Other expense

     

     

     

     

     

     

    Interest expense

     

     

    (2,231

    )

     

     

    (1,637

    )

    Other income (expense), net

     

     

    1,287

     

     

     

    (1,444

    )

    Total other expense, net

     

     

    (944

    )

     

     

    (3,081

    )

    Income before provision for income taxes

     

     

    12,608

     

     

     

    8,898

     

    Provision for income taxes

     

     

    (3,360

    )

     

     

    (1,970

    )

    Net income

     

    $

    9,248

     

     

    $

    6,928

     

     

     

     

     

     

     

     

    Net income per share:

     

     

     

     

     

     

    Basic

     

    $

    0.23

     

     

    $

    0.18

     

    Diluted

     

    $

    0.23

     

     

    $

    0.18

     

    Weighted average shares outstanding:

     

     

     

     

     

     

    Basic

     

     

    40,618,554

     

     

     

    37,946,576

     

    Diluted

     

     

    40,980,861

     

     

     

    38,554,185

     

     

    CADRE HOLDINGS, INC.

    CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

    (Unaudited)

    (In thousands)

     

     

     

     

     

     

     

     

     

    Three Months Ended March 31,

     

     

    2025

     

    2024

    Cash Flows From Operating Activities:

     

     

     

     

     

     

    Net income

     

    $

    9,248

     

     

    $

    6,928

     

    Adjustments to reconcile net income to net cash provided by operating activities:

     

     

     

     

     

     

    Depreciation and amortization

     

     

    3,856

     

     

     

    3,942

     

    Amortization of original issue discount and debt issue costs

     

     

    500

     

     

     

    149

     

    Amortization of inventory step-up

     

     

    —

     

     

     

    769

     

    Deferred income taxes

     

     

    533

     

     

     

    1,546

     

    Stock-based compensation

     

     

    1,968

     

     

     

    2,067

     

    Remeasurement of contingent consideration

     

     

    331

     

     

     

    451

     

    (Recoveries from) provision for losses on accounts receivable

     

     

    (17

    )

     

     

    480

     

    Unrealized foreign exchange transaction (gain) loss

     

     

    (731

    )

     

     

    934

     

    Other loss (gain)

     

     

    41

     

     

     

    52

     

    Changes in operating assets and liabilities, net of impact of acquisitions:

     

     

     

     

     

     

    Accounts receivable

     

     

    10,633

     

     

     

    2,696

     

    Inventories

     

     

    (9,143

    )

     

     

    1,818

     

    Prepaid expenses and other assets

     

     

    1,340

     

     

     

    2,028

     

    Accounts payable and other liabilities

     

     

    (1,168

    )

     

     

    (21,723

    )

    Net cash provided by operating activities

     

     

    17,391

     

     

     

    2,137

     

    Cash Flows From Investing Activities:

     

     

     

     

     

     

    Purchase of property and equipment

     

     

    (1,309

    )

     

     

    (1,343

    )

    Business acquisitions, net of cash acquired

     

     

    —

     

     

     

    (141,293

    )

    Net cash used in investing activities

     

     

    (1,309

    )

     

     

    (142,636

    )

    Cash Flows From Financing Activities:

     

     

     

     

     

     

    Proceeds from revolving credit facilities

     

     

    —

     

     

     

    5,500

     

    Principal payments on revolving credit facilities

     

     

    —

     

     

     

    (5,500

    )

    Proceeds from term loans

     

     

    —

     

     

     

    80,000

     

    Principal payments on term loans

     

     

    (2,813

    )

     

     

    (2,500

    )

    Principal payments on insurance premium financing

     

     

    —

     

     

     

    (1,083

    )

    Payments for debt issuance costs

     

     

    —

     

     

     

    (844

    )

    Taxes paid in connection with employee stock transactions

     

     

    (1,140

    )

     

     

    (5,311

    )

    Proceeds from secondary offering, net of underwriter discounts

     

     

    —

     

     

     

    73,535

     

    Deferred offering costs

     

     

    —

     

     

     

    (722

    )

    Dividends distributed

     

     

    (3,859

    )

     

     

    (3,289

    )

    Net cash (used in) provided by financing activities

     

     

    (7,812

    )

     

     

    139,786

     

    Effect of foreign exchange rates on cash and cash equivalents

     

     

    228

     

     

     

    74

     

    Change in cash and cash equivalents

     

     

    8,498

     

     

     

    (639

    )

    Cash and cash equivalents, beginning of period

     

     

    124,933

     

     

     

    87,691

     

    Cash and cash equivalents, end of period

     

    $

    133,431

     

     

    $

    87,052

     

    Supplemental Disclosure of Cash Flows Information:

     

     

     

     

     

     

    Cash paid for income taxes, net

     

    $

    2,017

     

     

    $

    9,369

     

    Cash paid for interest

     

    $

    3,527

     

     

    $

    2,498

     

    Supplemental Disclosure of Non-Cash Investing and Financing Activities:

     

     

     

     

     

     

    Accruals and accounts payable for capital expenditures

     

    $

    104

     

     

    $

    210

     

    Accruals for taxes paid in connection with employee stock transactions

     

    $

    24

     

     

    $

    —

     

     

    CADRE HOLDINGS, INC.

    SEGMENT INFORMATION

    (Unaudited)

    (In thousands)

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Three Months Ended March 31, 2025

     

     

     

     

     

     

     

     

    Reconciling

     

     

     

     

     

    Product

     

    Distribution

     

    Items(1)

     

    Total

    Net sales

     

    $

    112,735

     

    $

    27,862

     

    $

    (10,491)

     

    $

    130,106

    Cost of goods sold

     

     

    62,625

     

     

    21,841

     

     

    (10,491)

     

     

    73,975

    Gross profit

     

    $

    50,110

     

    $

    6,021

     

    $

    —

     

    $

    56,131

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Three Months Ended March 31, 2024

     

     

     

     

     

     

     

     

    Reconciling

     

     

     

     

     

    Product

     

    Distribution

     

    Items(1)

     

    Total

    Net sales

     

    $

    118,785

     

    $

    28,191

     

    $

    (9,116)

     

    $

    137,860

    Cost of goods sold

     

     

    67,764

     

     

    21,557

     

     

    (9,089)

     

     

    80,232

    Gross profit

     

    $

    51,021

     

    $

    6,634

     

    $

    (27)

     

    $

    57,628

    ____________________

    (1)

    Reconciling items consist primarily of intercompany eliminations and items not directly attributable to operating segments.

     

    CADRE HOLDINGS, INC.

    RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES

    (Unaudited)

    (In thousands)

     

     

    Year ended

     

    Three Months Ended

     

    Last Twelve

     

    December 31,

     

    March 31,

     

    Months

     

    2024

     

    2025

     

    2024

     

    March 31, 2025

    Net income

     

    $

    36,133

     

    $

    9,248

     

     

    $

    6,928

     

    $

    38,453

     

    Add back:

     

     

     

     

     

     

     

     

     

     

     

     

    Depreciation and amortization

     

     

    16,420

     

     

    3,856

     

     

     

    3,942

     

     

    16,334

     

    Interest expense

     

     

    7,822

     

     

    2,231

     

     

     

    1,637

     

     

    8,416

     

    Provision for income taxes

     

     

    18,085

     

     

    3,360

     

     

     

    1,970

     

     

    19,475

     

    EBITDA

     

    $

    78,460

     

    $

    18,695

     

     

    $

    14,477

     

    $

    82,678

     

    Add back:

     

     

     

     

     

     

     

     

     

     

     

     

    Restructuring and transaction costs(1)

     

     

    7,757

     

     

    698

     

     

     

    4,837

     

     

    3,618

     

    Other expense (income), net(2)

     

     

    4,721

     

     

    (1,287

    )

     

     

    1,444

     

     

    1,990

     

    Stock-based compensation expense(3)

     

     

    8,369

     

     

    1,968

     

     

     

    2,067

     

     

    8,270

     

    Stock-based compensation payroll tax expense(4)

     

     

    441

     

     

    92

     

     

     

    393

     

     

    140

     

    LTIP bonus(5)

     

     

    49

     

     

    —

     

     

     

    50

     

     

    (1

    )

    Amortization of inventory step-up(6)

     

     

    3,858

     

     

    —

     

     

     

    769

     

     

    3,089

     

    Contingent consideration expense(7)

     

     

    1,185

     

     

    331

     

     

     

    451

     

     

    1,065

     

    Adjusted EBITDA

     

    $

    104,840

     

    $

    20,497

     

     

    $

    24,488

     

    $

    100,849

     

    Adjusted EBITDA margin(8)

     

     

    18.5

    %

     

    15.8

     

    %

     

    17.8

    %

     

     

    ____________________
    (1)

    Reflects the "Restructuring and transaction costs" line item on our consolidated statements of operations, which primarily includes transaction costs composed of legal and consulting fees. In addition, this line item reflects a $1.8 million fee paid to Kanders & Company, Inc. for services related to the acquisition of Alpha Safety for the three months ended March 31, 2024, which is included in related party expense in the Company's condensed consolidated statements of operations.

    (2)

    Reflects the "Other income (expense), net" line item on our condensed consolidated statements of operations and primarily includes transaction gains and losses due to fluctuations in foreign currency exchange rates.

    (3)

    Reflects compensation expense related to equity and liability classified stock-based compensation plans.

    (4)

    Reflects payroll taxes associated with vested stock-based compensation awards.

    (5)

    Reflects the cost of a cash-based long-term incentive plan awarded to employees that vests over three years.

    (6)

    Reflects amortization expense related to the step-up inventory adjustment recorded as a result of our recent acquisitions.

    (7)

    Reflects contingent consideration expense related to the acquisition of ICOR.

    (8)

    Reflects Adjusted EBITDA / Net sales for the relevant periods.

     

    View source version on businesswire.com: https://www.businesswire.com/news/home/20250506706974/en/

    Gray Hudkins

    Cadre Holdings, Inc.

    203-550-7148

    [email protected]

    Investor Relations:

    The IGB Group

    Leon Berman / Matt Berkowitz

    212-477-8438 / 212-227-7098

    Get the next $CDRE alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CDRE

    DatePrice TargetRatingAnalyst
    2/21/2024$32.00 → $38.00Buy
    ROTH MKM
    1/22/2024Outperform → Mkt Perform
    Raymond James
    9/6/2022$30.00Buy
    BofA Securities
    8/31/2022$32.00Buy
    Jefferies
    3/11/2022$25.00 → $27.00Outperform
    Raymond James
    11/29/2021$24.00Buy
    Lake Street
    11/29/2021$23.00Overweight
    Stephens
    11/29/2021$20.00Hold
    Stifel
    More analyst ratings

    $CDRE
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Cadre Holdings Reports First Quarter 2025 Financial Results

      Capitalizes on Continued Strong Demand for Mission Critical Safety Equipment Completes Acquisition of Multiple Leading Nuclear Brands, Expanding Geographic Footprint Increased Guidance Reflects Completed Acquisition and Reaffirmed Organic Growth Expectations 2025 Outlook: Net Sales of $618 to $648 Million and Adjusted EBITDA of $112 to $122 Million Cadre Holdings, Inc. (NYSE:CDRE) ("Cadre" or "Company"), a global leader in the manufacturing and distribution of safety equipment and other related products for the law enforcement, first responder, military and nuclear markets, announced today its consolidated operating results for the three months ended March 31, 2025. Net sales of $130.

      5/6/25 4:15:00 PM ET
      $CDRE
      Industrial Specialties
      Health Care
    • Cadre Holdings Announces First Quarter 2025 Earnings and Conference Call Information

      Cadre Holdings, Inc. (NYSE:CDRE) ("Cadre" or "the Company"), a global leader in the manufacturing and distribution of safety equipment and other related products for the law enforcement, first responder, military and nuclear markets, announced today that it plans to release financial results for the first quarter that ended on March 31, 2025, on Tuesday, May 6, 2025, after the close of market trading. The company has scheduled a conference call to discuss these results on Wednesday, May 7, 2025, at 10:00 a.m. ET. The conference call will feature remarks by Warren Kanders, CEO and Chairman of the Board; Brad Williams, President; and Blaine Browers, Chief Financial Officer. To participate in

      4/23/25 4:15:00 PM ET
      $CDRE
      Industrial Specialties
      Health Care
    • Cadre Holdings Declares Quarterly Dividend of $0.095 Per Share

      Cadre Holdings, Inc. (NYSE:CDRE) ("Cadre" or "the Company"), a global leader in the manufacturing and distribution of safety equipment and other related products for the law enforcement, first responder, military and nuclear markets, today announced that its Board of Directors has declared a quarterly cash dividend of $0.095 per share, or $0.38 per share on an annualized basis. Cadre's dividend payment will be made on May 16, 2025 to shareholders of record as of the close of business on the record date of May 2, 2025. The declaration of any future dividend is subject to the discretion of the Company's Board of Directors. About Cadre Headquartered in Jacksonville, Florida, Cadre is a globa

      4/22/25 4:16:00 PM ET
      $CDRE
      Industrial Specialties
      Health Care

    $CDRE
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Amendment: SEC Form 4 filed by CHIEF FINANCIAL OFFICER Browers Blaine

      4/A - Cadre Holdings, Inc. (0001860543) (Issuer)

      4/24/25 4:47:07 PM ET
      $CDRE
      Industrial Specialties
      Health Care
    • Amendment: SEC Form 4 filed by PRESIDENT Williams Brad

      4/A - Cadre Holdings, Inc. (0001860543) (Issuer)

      4/24/25 4:45:45 PM ET
      $CDRE
      Industrial Specialties
      Health Care
    • Amendment: SEC Form 4 filed by CEO AND CHAIRMAN Kanders Warren B

      4/A - Cadre Holdings, Inc. (0001860543) (Issuer)

      4/24/25 4:45:13 PM ET
      $CDRE
      Industrial Specialties
      Health Care

    $CDRE
    SEC Filings

    See more
    • SEC Form 10-Q filed by Cadre Holdings Inc.

      10-Q - Cadre Holdings, Inc. (0001860543) (Filer)

      5/6/25 4:17:42 PM ET
      $CDRE
      Industrial Specialties
      Health Care
    • Cadre Holdings Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - Cadre Holdings, Inc. (0001860543) (Filer)

      5/6/25 4:15:16 PM ET
      $CDRE
      Industrial Specialties
      Health Care
    • Amendment: SEC Form SCHEDULE 13G/A filed by Cadre Holdings Inc.

      SCHEDULE 13G/A - Cadre Holdings, Inc. (0001860543) (Subject)

      4/29/25 4:15:29 PM ET
      $CDRE
      Industrial Specialties
      Health Care

    $CDRE
    Financials

    Live finance-specific insights

    See more
    • Cadre Holdings Reports First Quarter 2025 Financial Results

      Capitalizes on Continued Strong Demand for Mission Critical Safety Equipment Completes Acquisition of Multiple Leading Nuclear Brands, Expanding Geographic Footprint Increased Guidance Reflects Completed Acquisition and Reaffirmed Organic Growth Expectations 2025 Outlook: Net Sales of $618 to $648 Million and Adjusted EBITDA of $112 to $122 Million Cadre Holdings, Inc. (NYSE:CDRE) ("Cadre" or "Company"), a global leader in the manufacturing and distribution of safety equipment and other related products for the law enforcement, first responder, military and nuclear markets, announced today its consolidated operating results for the three months ended March 31, 2025. Net sales of $130.

      5/6/25 4:15:00 PM ET
      $CDRE
      Industrial Specialties
      Health Care
    • Cadre Holdings Announces First Quarter 2025 Earnings and Conference Call Information

      Cadre Holdings, Inc. (NYSE:CDRE) ("Cadre" or "the Company"), a global leader in the manufacturing and distribution of safety equipment and other related products for the law enforcement, first responder, military and nuclear markets, announced today that it plans to release financial results for the first quarter that ended on March 31, 2025, on Tuesday, May 6, 2025, after the close of market trading. The company has scheduled a conference call to discuss these results on Wednesday, May 7, 2025, at 10:00 a.m. ET. The conference call will feature remarks by Warren Kanders, CEO and Chairman of the Board; Brad Williams, President; and Blaine Browers, Chief Financial Officer. To participate in

      4/23/25 4:15:00 PM ET
      $CDRE
      Industrial Specialties
      Health Care
    • Cadre Holdings Declares Quarterly Dividend of $0.095 Per Share

      Cadre Holdings, Inc. (NYSE:CDRE) ("Cadre" or "the Company"), a global leader in the manufacturing and distribution of safety equipment and other related products for the law enforcement, first responder, military and nuclear markets, today announced that its Board of Directors has declared a quarterly cash dividend of $0.095 per share, or $0.38 per share on an annualized basis. Cadre's dividend payment will be made on May 16, 2025 to shareholders of record as of the close of business on the record date of May 2, 2025. The declaration of any future dividend is subject to the discretion of the Company's Board of Directors. About Cadre Headquartered in Jacksonville, Florida, Cadre is a globa

      4/22/25 4:16:00 PM ET
      $CDRE
      Industrial Specialties
      Health Care

    $CDRE
    Leadership Updates

    Live Leadership Updates

    See more
    • Cadre Holdings Appoints Gianmaria Delzanno to its Board of Directors

      Cadre Holdings, Inc. (NYSE:CDRE) ("Cadre" or "the Company"), a global leader in the manufacturing and distribution of safety equipment and other related products for the law enforcement, first responder, military and nuclear markets, announced the appointment of Gianmaria Delzanno to its board of directors, effective as of January 13, 2025. Current Director Nicholas Sokolow, who joined the board of Cadre's predecessor in July of 2012, will retire from the Company's board, effective as of January 31, 2025. Upon Mr. Sokolow's departure, Mr. Delzanno will replace Mr. Sokolow as the lead independent director and will also serve as Chairman of the Nominating and Corporate Governance Committee as

      1/13/25 4:15:00 PM ET
      $CDRE
      Industrial Specialties
      Health Care
    • Cadre Holdings Appoints Deborah DeCotis to its Board of Directors

      Cadre Holdings, Inc. (NYSE:CDRE) ("Cadre" or "the Company"), a global leader in the manufacturing and distribution of safety and survivability equipment for first responders, announced the appointment of Deborah DeCotis to its board of directors, effective immediately. With Ms. DeCotis' appointment, the Board will expand to five directors, four of whom are independent. Ms. DeCotis will also serve on the Company's Compensation Committee. Ms. DeCotis has over 45 years of financial, advisory and business operations experience with a successful track record of leadership across multiple global institutions and industries. She currently serves as Advisory Director at Morgan Stanley & Co., Inc.

      4/12/22 8:30:00 AM ET
      $CDRE
      Industrial Specialties
      Health Care
    • ElectraMeccanica Appoints Automotive Veteran, William Quigley III, to Board of Directors

      VANCOUVER, British Columbia, April 07, 2022 (GLOBE NEWSWIRE) -- ElectraMeccanica Vehicles Corp. (NASDAQ:SOLO) ("ElectraMeccanica" or the "Company"), a designer and manufacturer of electric vehicles revolutionizing the urban driving experience, today announced the appointment of William (Bill) Quigley III to its Board of Directors. Mr. Quigley is an accomplished leader with a proven track record in large enterprises specific to the automotive industry. With 30 plus years in the industry, Bill's career has included the following key roles: Executive Vice President and Chief Financial Officer at Dana Holding Corporation, an automotive, commercial vehicle and off-highway driveline, sealing an

      4/7/22 8:05:00 AM ET
      $CDRE
      $SOLO
      Industrial Specialties
      Health Care
      Auto Manufacturing
      Consumer Discretionary

    $CDRE
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Cadre Holdings Inc.

      SC 13G/A - Cadre Holdings, Inc. (0001860543) (Subject)

      11/12/24 9:50:14 AM ET
      $CDRE
      Industrial Specialties
      Health Care
    • SEC Form SC 13G filed by Cadre Holdings Inc.

      SC 13G - Cadre Holdings, Inc. (0001860543) (Subject)

      2/14/24 7:58:49 PM ET
      $CDRE
      Industrial Specialties
      Health Care
    • SEC Form SC 13G/A filed by Cadre Holdings Inc. (Amendment)

      SC 13G/A - Cadre Holdings, Inc. (0001860543) (Subject)

      2/12/24 4:15:31 PM ET
      $CDRE
      Industrial Specialties
      Health Care

    $CDRE
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • ROTH MKM reiterated coverage on Cadre Holdings with a new price target

      ROTH MKM reiterated coverage of Cadre Holdings with a rating of Buy and set a new price target of $38.00 from $32.00 previously

      2/21/24 9:51:23 AM ET
      $CDRE
      Industrial Specialties
      Health Care
    • Cadre Holdings downgraded by Raymond James

      Raymond James downgraded Cadre Holdings from Outperform to Mkt Perform

      1/22/24 7:15:32 AM ET
      $CDRE
      Industrial Specialties
      Health Care
    • BofA Securities initiated coverage on Cadre Holdings with a new price target

      BofA Securities initiated coverage of Cadre Holdings with a rating of Buy and set a new price target of $30.00

      9/6/22 7:24:20 AM ET
      $CDRE
      Industrial Specialties
      Health Care